论文部分内容阅读
目的:分析消化道出血患者口服凝血酶治疗的临床效果。方法:随机选取2013年1月至2013年6月我院收治的消化道出血患者76例,按照数字随机表分为治疗组(38例)和对照组(38例)。对照组采取奥美拉唑治疗,治疗组在对照组基础上采用凝血酶治疗,分析其治疗效果。结果:治疗组总有效率为94.7%,对照组总有效率为78.9%;组间对比(P<0.05)。治疗组止血时间及住院时间均少于对照组(P<0.05)。治疗组复发率为2.6%,对照组复发率为23.7%;两组对比(P<0.01)。结论:患者口服凝血酶可明显改善消化道出血症状,提高治疗效果,止血迅速,值得临床推广。
Objective: To analyze the clinical effect of oral thrombin treatment in patients with gastrointestinal bleeding. Methods: A total of 76 patients with gastrointestinal hemorrhage admitted from January 2013 to June 2013 in our hospital were randomly divided into treatment group (38 cases) and control group (38 cases) according to the digital randomized table. The control group was treated with omeprazole, the treatment group was treated with thrombin on the basis of the control group, and the treatment effect was analyzed. Results: The total effective rate was 94.7% in the treatment group and 78.9% in the control group (P <0.05). The bleeding time and hospital stay in the treatment group were less than those in the control group (P <0.05). The recurrence rate was 2.6% in the treatment group and 23.7% in the control group (P <0.01). Conclusion: Patients with oral thrombin can significantly improve the symptoms of gastrointestinal bleeding, improve the therapeutic effect, stop bleeding quickly, worthy of clinical promotion.